Try our mobile app
ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) COMPLETION OF THE ACQUISITION OF DISTRIBUTION AND PROMOTION RIGHTS IN SOUTH AFRICA AND CERTAIN SUB-SAHARAN AFRICAN COUNTRIES FROM LILLY Shareholders are referred to the announcement of 30 August 2023 wherein it was confirmed that Aspen had concluded an agreement with Eli Lilly Export S.A., a subsidiary of Eli Lilly and Company (Lilly), in terms of which Aspen will distribute and promote Lilly’s products in South Africa and certain other Sub-Saharan African countries (the “Territory” and the “Transaction”). Aspen is pleased to confirm that all conditions precedents have been fulfilled. In accordance with the agreed terms, the Transaction will come into effect in South Africa, and other countries within the Southern African Development Community, on 1 January 2024. In the balance of the Territory, the Transaction is anticipated to become effective in the second quarter of calendar year 2024. Durban 6 December 2023 Sponsor Investec Bank Limited
